Welcome to the StockTalk Podcast…where we help listeners and investors understand more about investment opportunities in capital markets. I’m Dave Jackson.
Voyageur Pharmaceuticals (
TSX-V.VM,
OTC: VYYRF,
Forum) has built a successful business model from the ground-floor up based on sound principles with a focus on developing barium and iodine radiocontrast products and bromine based-pharmaceutical products. The Company provides its products to medical applications and diagnostics.
Through its three subsidiaries – Voyageur Industrial Minerals, Voyageur Inc., and a Joint Venture with Chief Medical Supply called ImagingX Pharmaceuticals – the Calgary-based company is executing on a model that will see it control all input costs from mineral production to pharmaceutical manufacturing to manufacture radiocontrast in bottles for distribution. Chief Medical has one of the largest pharmaceutical manufacturing facilities in North America in Mississauga, Ontario, with multiple lines capable of producing over 500 sterile bottles per minute.
In this podcast, Stockhouse Media's Dave Jackson was joined by the Company’s CEO & Director, Brent Willis, to learn more about Voyageur’s corporate vision, recent management team appointments, and the company’s unique business model.
FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing.